During a live event, Benjamin Garmezy, MD, discussed combinations regimens used for patients with renal cell carcinoma after ...

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...

Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...

Is the WaPo journalistically challenged when it comes to science? You decide. An April 6 article in the Washington Post, one ...

Nephrology is specialty of medicine concerned with kidney physiology, kidney disease, the treatment of kidney problems and renal replacement therapy. Systemic conditions that affect the kidneys (e ...

First, I'd like to provide updates on ST-503, our investigational epigenetic regulator for the treatment of chronic ... who began the study on enzyme replacement therapy, or ERT, have been ...

BSX aims to expand its Interventional Cardiology Therapies offerings with ultrasound-based renal denervation therapy for the treatment of ... aortic valve replacement. Last month, Medtronic ...

An April 6 article in the WaPo, one of the most recent as the NIH undergoes administrative changes, claims, “A big step forward in cancer therapy has been slowed by layoffs and ...

Cell therapy is distinguished by its potential to replace ... In addition, there have been complications derived from the immunosuppressive treatment in some patients, such as renal impairment, anemia ...

Follow-up after joint replacement surgery ... up X-rays to assess the joint and compare it to earlier X-rays Check-up to assess how your recovery is going (e.g., range of motion, strength) and any ...

The hypertensive index may predict the likelihood of kidney function improvement following renal revascularization for renal artery stenosis. The hypertensive index may distinguish which patients with ...

The FDA has approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.